Norethindrone

Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.

Cross Reference

Introduction

To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Norethindrone?

Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Norethindrone

MeSH term MeSH ID Detail
Pancreatic Neoplasms D010190 77 associated lipids
Arteriosclerosis D001161 86 associated lipids
Body Weight D001835 333 associated lipids
Total 3

PubChem Associated disorders and diseases

What pathways are associated with Norethindrone

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Norethindrone?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Norethindrone?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Norethindrone?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Norethindrone?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Norethindrone?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Norethindrone

Download all related citations
Per page 10 20 50 100 | Total 3869
Authors Title Published Journal PubMed Link
Kappus H and Bolt HM Proceedings: Covalent protein binding of norethisterone and norethisterone-4,5-epoxide in liver microsomes. 1975 Naunyn Schmiedebergs Arch. Pharmacol. pmid:1143488
Anand Kumar TC et al. Ovulation in rhesus monkeys suppressed by intranasal administration of progesterone and norethisterone. 1977 Nature pmid:413055
Savithiri S et al. Scaling analysis for the investigation of slip mechanisms in nanofluids. 2011 Nanoscale Res Lett pmid:21791036
Drbohlavova J et al. Self-ordered TiO2 quantum dot array prepared via anodic oxidation. 2012 Nanoscale Res Lett pmid:22333295
Ishigami R et al. [Studies on drug diabetes. Abnormal carbohydrate metabolism caused by oral contraceptive agents]. 1968 Naika Hokan pmid:5690963
Gruhn K et al. [Effect of contraceptives on the digestibility of dietary protein and nitrogen balance]. 1981 Nahrung pmid:7290175
Cerin A et al. Adverse endometrial effects of long-cycle estrogen and progestogen replacement therapy. The Scandinavian LongCycle Study Group. 1996 N. Engl. J. Med. pmid:8592546
Petri M et al. Combined oral contraceptives in women with systemic lupus erythematosus. 2005 N. Engl. J. Med. pmid:16354891
Szabo AJ et al. Glucose tolerance in gestational diabetic women during and after treatment with a combination-type oral contraceptive. 1970 N. Engl. J. Med. pmid:5417729
Godsland IF et al. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. 1990 N. Engl. J. Med. pmid:2146499
Hirvonen E et al. Effects of different progestogens on lipoproteins during postmenopausal replacement therapy. 1981 N. Engl. J. Med. pmid:7453723
BREIBART S et al. Progestins and skeletal maturation. 1963 N. Engl. J. Med. pmid:14015188
Selby PL and Peacock M Ethinyl estradiol and norethindrone in the treatment of primary hyperparathyroidism in postmenopausal women. 1986 N. Engl. J. Med. pmid:3754618
Whitehead MI et al. Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium. 1981 N. Engl. J. Med. pmid:7312007
Kilpatrick ZM et al. Vascular occlusion of the colon and oral contraceptives. Possible relation. 1968 N. Engl. J. Med. pmid:5636665
Heinonen OP et al. Cardiovascular birth defects and antenatal exposure to female sex hormones. 1977 N. Engl. J. Med. pmid:830309
ROGERS J MENSTRUAL DISORDERS. 1964 N. Engl. J. Med. pmid:14092181
Davidoff F et al. Marked hyperlipidemia and pancreatitis associated with oral contraceptive therapy. 1973 N. Engl. J. Med. pmid:4723103
BETZ G and WARREN JC Hydrolysis of norethindrone acetate by fetal and placental tissue. 1963 N. Engl. J. Med. pmid:13967871
Braverman DZ et al. Effects of pregnancy and contraceptive steroids on gallbladder function. 1980 N. Engl. J. Med. pmid:7351927
PEREZ-MERA RA and SHIELDS CE Jaundice associated with norethindrone acetate therapy. 1962 N. Engl. J. Med. pmid:13942388
Lidegaard Ø et al. Thrombotic stroke and myocardial infarction with hormonal contraception. 2012 N. Engl. J. Med. pmid:22693997
Jensen J et al. Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause. 1985 N. Engl. J. Med. pmid:4047104
Gregg WI Galactorrhea after contraceptive hormones. 1966 N. Engl. J. Med. pmid:5949006
Wahl P et al. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol. 1983 N. Engl. J. Med. pmid:6572785
FLOWERS CE THE USE OF PROGESTINS IN OBSTETRICS AND GYNECOLOGY. 1964 N C Med J pmid:14143212
Shyama SK et al. Genotoxic effect of Anovlar 21, an oral contraceptive, on mouse bone marrow. 1991 Mutat. Res. pmid:2027340
Murthy PB and Prema K Further studies on sister-chromatid exchange frequency in users of hormonal contraceptives. 1983 Mutat. Res. pmid:6402698
Röhrborn G and Hansmann I Oral contraceptives and chromosome segregation in oocytes of mice. 1974 Mutat. Res. pmid:4431427
Ahmad ME et al. Evaluation of genotoxic potential of synthetic progestins-norethindrone and norgestrel in human lymphocytes in vitro. 2001 Mutat. Res. pmid:11423341
Martelli A et al. Species, sex and inter-individual differences in DNA repair induced by nine sex steroids in primary cultures of rat and human hepatocytes. 2003 Mutat. Res. pmid:12694747
Shyama SK and Abdul Rahiman M Progestin (norethisterone)-induced genetic damage in mouse bone marrow. 1993 Mutat. Res. pmid:7687021
Dhillon VS and Dhillon IK Genotoxicity evaluation of norethisterone acetate. 1996 Mutat. Res. pmid:8596541
Martelli A et al. Induction of micronuclei and of enzyme-altered foci in the liver of female rats exposed to progesterone and three synthetic progestins. 1998 Mutat. Res. pmid:9804880
Badr FM and Badr RS Studies on the mutagenic effect of contraceptive drugs. I. Induction of dominant lethal mutations in female mice. 1974 Mutat. Res. pmid:4431426
Kabarity A and Mazrooei S Further investigations on the cytological effects of some contraceptives. 1984 Mutat. Res. pmid:6708960
Notter G and Wicklund H [Treatment of inoperable and metastasizing breast cacinoma with gestagen hormones]. 1967 Munch Med Wochenschr pmid:5632005
Szarvas Z [Peculiar secretory activity of endometrial cancer cells during progestational therapy]. 1978 Morphol Igazsagugyi Orv Sz pmid:714043
Litzke F et al. [Use of norethisterone acetate for the control of reproduction in cattle]. 1971 Monatsh Veterinarmed pmid:5170110
Liu X et al. Probing Steroidal Substrate Specificity of Cytochrome P450 BM3 Variants. 2016 Molecules pmid:27294908
Yao K et al. Electromagnetic noise inhibits radiofrequency radiation-induced DNA damage and reactive oxygen species increase in human lens epithelial cells. 2008 Mol. Vis. pmid:18509546
Castro I et al. Molecular mechanisms of the antihormonal and antiimplantation effects of norethisterone and its A-ring reduced metabolites. 1995 Mol. Reprod. Dev. pmid:7766408
Hodder AN et al. Analysis of structure and function of the giant protein Pf332 in Plasmodium falciparum. 2009 Mol. Microbiol. pmid:19007413
Manoharan C et al. The role of charged residues in the transmembrane helices of monocarboxylate transporter 1 and its ancillary protein basigin in determining plasma membrane expression and catalytic activity. 2006 Nov-Dec Mol. Membr. Biol. pmid:17127621
Kohnen G et al. Endothelin receptor expression in human decidua. 1998 Mol. Hum. Reprod. pmid:9542978
Hampton AL et al. Progesterone analogues similarly modulate endometrial matrix metalloproteinase-1 and matrix metalloproteinase-3 and their inhibitor in a model for long-term contraceptive effects. 1999 Mol. Hum. Reprod. pmid:10321809
Gao J et al. Ligand-activated progesterone receptor isoform hPR-A is a stronger transactivator than hPR-B for the expression of IGFBP-1 (insulin-like growth factor binding protein-1) in human endometrial stromal cells. 2000 Mol. Endocrinol. pmid:11117526
Jeng MH and Jordan VC Growth stimulation and differential regulation of transforming growth factor-beta 1 (TGF beta 1), TGF beta 2, and TGF beta 3 messenger RNA levels by norethindrone in MCF-7 human breast cancer cells. 1991 Mol. Endocrinol. pmid:1834933
Attardi BJ et al. Relative progestational and androgenic activity of four progestins used for male hormonal contraception assessed in vitro in relation to their ability to suppress LH secretion in the castrate male rat. 2010 Mol. Cell. Endocrinol. pmid:20599585
Koubovec D et al. Synthetic progestins used in HRT have different glucocorticoid agonist properties. 2005 Mol. Cell. Endocrinol. pmid:16125839